Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

Siemens and Perceptive Engineering partner to provide a versatile solution for the Pharmaceutical Industry

NUREMBERG, 07-Feb-2018 — /EuropaWire/ — Siemens AG and Perceptive Engineering Ltd announce a partnership which offers Perceptive’s PharmaMV and Siemens Simatic Sipat software products closely integrated to provide a versatile solution for advanced control and optimization applications in both continuous and … Read the full press release

University of Glasgow and Portage Pharmaceuticals to develop more effectively-targeted drugs to treat chronic diseases including cancer

GLASGOW, 05-Feb-2018 — /EuropaWire/ — A new joint venture company which brings together the University of Glasgow and Portage Pharmaceuticals is aiming to develop more effectively-targeted drugs to treat chronic conditions including cancer. Portage Pharmaceuticals, a subsidiary of the British Virgin … Read the full press release

The University of Southampton reaches £25m target to fund the UK’s first dedicated centre for cancer immunology research

SOUTHAMPTON, 02-Feb-2018 — /EuropaWire/ — The University of Southampton is delighted to announce it has reached its £25m target to fund the UK’s first dedicated centre for cancer immunology research. For decades, Southampton scientists have made a number of advances … Read the full press release

Sanofi acquires Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders

Expands Sanofi’s presence in specialty care and strengthens leadership in rare diseases  Adds leader in the growing hemophilia market and provides platform for expansion in other rare blood disorders  Drives meaningful shareholder value with ROIC expected to exceed cost of … Read the full press release

Medicinal Chemistry: Peter D.J. Grootenhuis is the recipient of the 2018 IUPAC-Richter Prize for outstanding creative contributions in the treatment of cystic fibrosis

The 2018 IUPAC-Richter Prize in Medicinal Chemistry has been awarded to Peter D.J. Grootenhuis. BUDAPEST, 30-Jan-2018 — /EuropaWire/ — Peter D.J. Grootenhuis received this award in recognition of his outstanding creative contributions to the invention, discovery, and development of the medicine … Read the full press release

Merck appoints Dirk Toepfer as new Chief Information Officer

Toepfer joins from Metro Group, where he served as Head of the IT service company Metro Systems DARMSTADT, 26-Jan-2018 — /EuropaWire/ — Merck, a leading science and technology company, today announced that Dirk Toepfer will join the Group as the new … Read the full press release

Innovate UK: Industrial Strategy Challenge Fund to provide £70 million to help speed up the development of new medicines

LONDON, 22-Jan-2018 — /EuropaWire/ — Science Minister Sam Gyimah announces £70 million to create new manufacturing centres to help speed up the development of new medicines. Funding through Industrial Strategy Challenge Fund (ISCF) will support projects including new manufacturing centres to speed … Read the full press release

AstraZeneca: Japan approval for Lynparza (olaparib) tablets for use as a maintenance therapy for patients with platinum-sensitive relapsed ovarian cancer

Lynparza is the first PARP inhibitor approved in Japan Lynparza tablets approved as maintenance treatment for women with platinum-sensitive relapsed ovarian cancer regardless of BRCA mutation status CAMBRIDGE, 22-Jan-2018 — /EuropaWire/ — AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, … Read the full press release

UK Education Consultancy Services Ltd announced that the premiere issue of Scientific European® (a popular science magazine) is released on 19 January 2018

Scientific European® (a popular science magazine) launched Tadworth, Surrey, United Kingdom, 20-Jan-2018 — /EuropaWire/ — UK Education Consultancy Services Ltd announced that the premiere issue of Scientific European® (a popular science magazine) is released today on 19 January 2018. Abbreviated … Read the full press release

Medtronic’s Neurovascular business unit received U.S. FDA clearance of the Riptide(TM) Aspiration System

New System Expands Neurovascular Product Portfolio for the Treatment of Acute Ischemic Stroke DUBLIN, 17-Jan-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced that the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, … Read the full press release

Shire CMO Howard Mayer, M.D.: no patient is currently being denied access to treatment with Hemlibra

DUBLIN, 16-Jan-2018 — /EuropaWire/ — At Shire, we’ve been committed to the hemophilia community and the lives of every patient afflicted with this disease for more than 70 years. We are very proud of this legacy and take our role as … Read the full press release

Shire: EU approval of ADYNOVI is an important milestone in our continued commitment to provide new treatment options for patients with hemophilia A

Marketing Authorization will enable patient access to ADYNOVI throughout Europe ZUG, 16-Jan-2018 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare diseases, announced today that the European Commission (EC) has granted Marketing Authorization for ADYNOVI … Read the full press release

Cosmetagora: BASF presents new active ingredients for skin and hair care products

Anti-stress ingredient Hyalurosmooth® is a mindful way to cope with the effect of stress by regulating cortisol impact on skin New anti-aging active RNAge™ harnesses BASF’s findings in epigenetics and reshapes facial harmony Anti-aging active DN-Age™ slows down hair graying, counteracts hair loss … Read the full press release

NYSCC Cosmetic Congress: BASF Care Creations and the Cell Therapy Research Institute CTIBiotech reveal initial results of their joint research on 3D tissue models

Experts demonstrated both ex vivo production of physiological sebum in 3D human sebaceous gland model and its regulation by means of active ingredients Ludwigshafen, Germany, 10-Jan-2018 — /EuropaWire/ — Sebaceous glands help the skin stay moist and protect it against external … Read the full press release

Novartis: US FDA grants Breakthrough Therapy designation to Promacta® (eltrombopag) for the treatment of patients with SAA

Data supporting designation showed over half of treatment-naïve SAA patients achieved complete response with Promacta when given with standard immunosuppressive therapy, with overall response rate of 85%[1] Promacta is the only TPO receptor agonist indicated for the treatment of patients … Read the full press release

University of Warwick: biotechnology firm VirionHealth receives non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA)

Coventry, UK, 08-Jan-2018 — /EuropaWire/ — VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has won non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA). … Read the full press release

Shire plc files its first submission to the US FDA for its new plasma manufacturing facility in Covington, GA

DUBLIN, 02-Jan-2018 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare diseases, today announced that it has filed its first submission to the United States Food and Drug Administration for the company’s new plasma manufacturing … Read the full press release

New substance discovered against life-threatening tuberculosis infections

MUNICH, 29-Dec-2017 — /EuropaWire/ — In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They … Read the full press release

Roche to fully acquire Ignyta for US$ 1.7 billion in an all-cash transaction

Roche to acquire Ignyta for US$ 27.00 per share Ignyta’s investigational medicine entrectinib, a selective CNS-active tyrosine-kinase inhibitor being developed for tumours that harbor ROS1 or NTRK fusions, to expand Roche’s portfolio of oncology medicines BASEL, 27-Dec-2017 — /EuropaWire/ — … Read the full press release

Medtronic plc announces leadership changes

Bryan Hanson Leaves Medtronic to Become President and CEO of a Public Company DUBLIN, 20-Dec-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of Medtronic’s Asia Pacific (APAC) Region, has been … Read the full press release